Health spending has started to rise again after stagnating or even falling in many OECD countries during the crisis. But the pace of growth remains well below pre-crisis rates, especially in Europe, according to OECD Health Statistics 2014.
Strengthening primary health care and prevention programmes would help stem the growing tide of diabetes and other chronic health conditions in the Czech Republic, according to a new OECD report.
OECD governments have to decide whether they want to cover more services at a limited reimbursement rate, or whether they want to extend more the financial protection for a limited number of services.
The 2012 HSC Survey identifies policy responses to tackle possible issues with problems of physician supply in OECD countries and takes stock of the employment status of doctors, their training and various issues concerning regulations of this medical profession.
The pricing of specialist and hospital services is a contentious issue in South Africa. To help inform domestic debates, the OECD Secretariat has produced a paper profiling international experiences on the pricing of specialist medical services services, competition policy and models of buying services from the private sector.
April edition of the OECD Health Division newsletter, focusing on Training on SHA 2011, The Latin American International Diabetes Forum and The European Diabetes Leadership Forum 2014, OECD work on Pharmaceutical Policy, Health spending, Geographic imbalances in doctor supply and policy responses, and upcoming publications.
Synthetic biology is an emerging technology that shows promise for investigating some of the burning issues in biological research. It also has the potential to address some of the grand challenges facing society, such as climate change and energy security.
Expenditure by disease data based on national health accounts can provide valuable information for use in policy analysis. In order to move further in this important area, it is necessary both to refine the definitions and approach that is followed, but also to demonstrate that such accounts can be developed in a cost-effective manner under the framework of the System of Health Accounts.
English, PDF, 1,664kb
This Final Report focuses on the cost of illness, a contextual review of the System of Health Accounts 2011, a summary of overall data availability, background, methodology and results of the hospital expenditure modelling, allocating pharmaceutical data by disease, and allocating ambulatory expenditure by disease.
Most people in OECD countries are overweight or obese. The social and economic consequences of this epidemic are dramatic, exposing an increasing number of people to chronic diseases such as diabetes, heart disease and cancer.